Novo Nordisk wants to keep its crown leading the weight loss drugs pack—despite outlook downgrades and lawsuits, its CFO has a plan

The real snag will come in the next decade: The U.S. represents 50% of group sales for Novo, and while there is a “good ...
Fierce Healthcare

Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...
Morningstar

Novo Nordisk Says Wegovy Weight-Loss Pill Matches Shot as it Eyes Landmark Approval

Novo Nordisk's experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late-stage trial. The pill has already been sent to ...
Wall Street Journal

Novo Nordisk’s Wegovy Pill Shows Similar Weight-Loss to Its Shot, Study Finds

Novo Nordisk’s NOVO.B3.02%increase; green up pointing triangle experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late ...

Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies

Novo Nordisk and Pfizer have submitted improved offers for US weight-loss start-up Metsera, but the coveted biotech continues ...

Pfizer sues Novo, Metsera for second time in brewing deal war

Pfizer Inc. accused Novo Nordisk A/S of trying to stifle competition in the weight-loss market by attempting to acquire ...